A drug with the SMILES Nc1c2c(nc3cccc(Cl)c13)N(c1ccccc1)CC2 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 31.741%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Nc1c2c(nc3cccc(Cl)c13)N(c1ccccc1)CC2
Nc1c2c(nc3cccc(Cl)c13)N(c1ccccc1)CC2
5-chloro-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-amine